Institute of BioMedical Research Corp. (MRES)
0.0030
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Institute of BioMedical Research Enterprise Value : 8.641M for Sept. 4, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 8.641M |
| September 03, 2026 | 9.812M |
| September 02, 2026 | 11.54M |
| September 01, 2026 | 11.54M |
| August 31, 2026 | 11.54M |
| August 28, 2026 | 11.25M |
| August 27, 2026 | 8.946M |
| August 26, 2026 | 5.197M |
| August 25, 2026 | 5.197M |
| August 24, 2026 | 5.197M |
| August 21, 2026 | 5.197M |
| August 20, 2026 | 5.197M |
| August 19, 2026 | 5.486M |
| August 18, 2026 | 5.486M |
| August 17, 2026 | 4.658M |
| August 14, 2026 | 4.303M |
| August 13, 2026 | 3.294M |
| August 12, 2026 | 3.178M |
| August 11, 2026 | 3.178M |
| August 10, 2026 | 3.178M |
| August 07, 2026 | 3.957M |
| August 06, 2026 | 3.957M |
| August 05, 2026 | 3.467M |
| August 04, 2026 | 3.467M |
| August 03, 2026 | 3.467M |
| Date | Value |
|---|---|
| July 31, 2026 | 3.467M |
| July 30, 2026 | 3.467M |
| July 29, 2026 | 3.467M |
| July 28, 2026 | 3.467M |
| July 27, 2026 | 3.467M |
| July 24, 2026 | 3.467M |
| July 23, 2026 | 3.467M |
| July 22, 2026 | 3.467M |
| July 21, 2026 | 3.467M |
| July 20, 2026 | 3.467M |
| July 17, 2026 | 3.178M |
| July 16, 2026 | 4.044M |
| July 15, 2026 | 3.755M |
| July 14, 2026 | 3.640M |
| July 13, 2026 | 3.467M |
| July 10, 2026 | 3.467M |
| July 09, 2026 | 3.467M |
| July 08, 2026 | 3.308M |
| July 07, 2026 | 2.890M |
| July 06, 2026 | 2.867M |
| July 02, 2026 | 2.717M |
| July 01, 2026 | 2.717M |
| June 30, 2026 | 3.467M |
| June 29, 2026 | 3.210M |
| June 26, 2026 | 3.757M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Brainstorm Cell Therapeutics, Inc. | 12.94M |
| Cavitation Technologies, Inc. | 14.70M |
| Clene, Inc. | 61.87M |
| Bon Natural Life Ltd. | -- |
| Biohaven Ltd. | 2.399B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0515M |
| Revenue (Quarterly) | 0.025M |
| Total Expenses (Quarterly) | 0.0436M |
| Profit Margin (Quarterly) | -206.0% |
| Earnings Yield | -10.02% |
| Normalized Earnings Yield | 13.36 |